Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4620-4627, Vol. 67, No. 9
Department of Microbiology and Infectious
Diseases1 and Department of Internal
Medicine,3 University of Calgary, Calgary,
Alberta, Canada T2N 4N1, and Department of Microbiology,
University of Nevada, Reno, Nevada 595572
Received 28 December 1998/Returned for modification 27 January
1999/Accepted 3 June 1999
Cell-mediated immunity is critical for the host defense to
Cryptococcus neoformans, as demonstrated by numerous
animal studies and the prevalence of the infection in AIDS patients.
Previous studies have established that the polysaccharide capsule
contributes to the virulence of C. neoformans by
suppressing T-lymphocyte proliferation, which reflects the clonal
expansion of T lymphocytes that is a hallmark of cell-mediated
immunity. The present studies were performed to identify the major
mechanism by which polysaccharide impairs lymphocyte proliferation,
since capsular polysaccharide has the potential to affect the
development of T-lymphocyte responses by stimulating production
of interleukin-10 (IL-10), inhibiting phagocytosis, and inducing
shedding of cell surface receptors. We demonstrate that polysaccharide
inhibits lymphocyte proliferation predominantly by blocking uptake
of C. neoformans, which is crucial for subsequent
lymphocyte proliferation. In addition, we show that polysaccharide did
not suppress lymphocyte proliferation via an IL-10-dependent
mechanism, nor did it affect critical surface receptor interactions on
the T cell or antigen-presenting cell. Having established that
polysaccharide impairs phagocytosis, we performed studies to determine
whether opsonization with human serum or with anticapsular antibody
could reverse this effect. Impaired uptake and lymphocyte proliferation
that were induced by polysaccharide can be enhanced through
opsonization with monoclonal antibodies or human serum, suggesting that
antipolysaccharide antibodies might enhance the host defense by
restoring uptake of the organism and subsequent presentation to T
lymphocytes. These studies support the therapeutic potential of
stimulating cell-mediated immunity to C. neoformans with
anticapsular antibody.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Capsule of Cryptococcus neoformans Reduces
T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be
Restored with Anticapsular Antibody
*
Corresponding author. Mailing address: Division of
Pulmonary Medicine, Room 273, Heritage Medical Research Building,
University of Calgary, 3330 Hospital Dr. NW, Calgary, Alberta, Canada
T2N 4N1. Phone: (403) 220-5979. Fax: (403) 270-2772. E-mail:
cmody{at}ucalgary.ca.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|